Newsletter | August 22, 2019

08.22.19 -- Forging The Path For Efficient And Economical Viral Vector Production

Tips For Viral Vector Production

The viral vector market is highly active, and the interest in production technologies is driven by recent approvals in cell and gene therapy. Here, insights around the challenges in viral vector manufacturing are shared so that a scalable and cost-efficient process suitable for GMP manufacturing environments can be obtained.

Translating Biopharma Knowledge To Solve Complexities Of Cell And Gene Therapy Manufacturing

Streamlining, connecting, and automating workflows to shape the future of cellular treatment delivery has the potential to transform how we treat and potentially cure once life-threatening diseases.

How Modular Facilities Are Helping Scale Up Manufacturing Of Viral Vector-Based Therapies

Manufacturing viral vector-based therapies such as vaccines and gene and cell therapies is complex, but a new manufacturing solution helps solve those challenges.